Ra Pharmaceuticals Inc Forecast and Stock Analysis
Technical RARX stock analysis for February 15, 2019.
Ra Pharmaceuticals Inc fell by -1.38% in the last day from $20.33 to $20.05 The price has been going up and down for this period, and there has been a -4.52% loss for the last 2 weeks. Volume has increased in the last day by 48 052 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 186 835 shares bought and sold for approximately $3.75 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the RARX stock was $20.05. This is 1.38% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 4.04% from a day low at $19.56 to a day high of $20.35.
30 day high of the RARX stock price was $22.25 and low was $18.35.
90 day high was $23.90 and low was $13.73.
52 week high for the Ra Pharmaceuticals Inc - $23.90 and low - $4.78.
Ra Pharmaceuticals Inc lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $18.91 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 31.62% during the next 3 months and, with 90% probability hold a price between $24.88 and $34.85 at the end of this period.
There are few to none technical positive signals at the moment. Ra Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $20.27. On a fall, the stock will find some support from the short-term average at $20.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Thursday February 14, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 55 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $17.62 and $17.06.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ra Pharmaceuticals Inc finds support just below today's level at $17.62. If this is broken, then the next support from accumulated volume will be at $17.06 and $15.91.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.79 (4.04%) between high and low. For the last week, the stock has had a daily average volatility of 5.18%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Ra Pharmaceuticals Inc stock holds several negative signals and despite the positive trend we believe Ra Pharmaceuticals Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.